Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study.

MLA

Hozuki, Takayoshi, et al. “Response of Serum Carboxylated and Undercarboxylated Osteocalcin to Risedronate Monotherapy and Combined Therapy with Vitamin K(2) in Corticosteroid-Treated Patients: A Pilot Study.” Internal Medicine (Tokyo, Japan), vol. 49, no. 5, 2010, pp. 371–76. EBSCOhost, https://doi.org/10.2169/internalmedicine.49.2551.

APA

Hozuki, T., Imai, T., Tsuda, E., Matsumura, A., Yamamoto, D., Toyoshima, T., Suzuki, S., Yamauchi, R., Hayashi, T., Hisahara, S., & Shimohama, S. (2010). Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study. Internal Medicine (Tokyo, Japan), 49(5), 371–376. https://doi.org/10.2169/internalmedicine.49.2551

Chicago

Hozuki, Takayoshi, Tomihiro Imai, Emiko Tsuda, Akihiro Matsumura, Daisuke Yamamoto, Takanobu Toyoshima, Syuuichiro Suzuki, et al. 2010. “Response of Serum Carboxylated and Undercarboxylated Osteocalcin to Risedronate Monotherapy and Combined Therapy with Vitamin K(2) in Corticosteroid-Treated Patients: A Pilot Study.” Internal Medicine (Tokyo, Japan) 49 (5): 371–76. doi:10.2169/internalmedicine.49.2551.